Targeting MALAT1 in vivo with antisense oligonucleotides (ASO)-MALAT1 treatment effectively suppressed the progression of xenograft tumors and orthotopic liver tumors in HBx-related HCC. Here, MALAT1 is linked to hepatocellular carcinoma.